Vulnerability to nicotine abstinence-related social anxiety-like behavior: Molecular correlates in neuropeptide Y, Y2 receptor and corticotropin releasing factor

Neuroscience Letters

Volumn 490, Issue 3, 2011, Pages 220-225

  Aydin, Cigdem ^a   Oztan, Ozge ^a   Isgor, Ceylan ^a  

^a FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

Anxiety like behavior; Central nucleus of amygdala; Hippocampus; Locomotor sensitization; Medial nucleus of amygdala; Novelty seeking phenotype

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; NEUROPEPTIDE Y; NEUROPEPTIDE Y2 RECEPTOR; NICOTINE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOKING CESSATION; SOCIAL BEHAVIOR; SOCIAL INTERACTION;

AMYGDALA; ANIMALS; ANXIETY; CA1 REGION, HIPPOCAMPAL; CONDITIONING, OPERANT; CORTICOTROPIN-RELEASING HORMONE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; LOCOMOTION; MALE; NEUROPEPTIDE Y; NICOTINE; NICOTINIC AGONISTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROPEPTIDE Y; RNA, MESSENGER; TOBACCO USE DISORDER;

EID: 79551593494     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.12.056     Document Type: Article

References (24)

1. Bhatti A.S., Hall P., Tao R., Isgor C. Hippocampus modulates the behaviorally sensitizing effects of nicotine in a rat model of novelty-seeking: potential role for mossy fibers. Hippocampus 2007, 17:922-933.
2. Bhatti A.S., Aydin C., Oztan O., Ma Z., Hall P., Tao R., Isgor C. Effects of a cannabinoid receptor (CB) 1 antagonist AM251 on behavioral sensitization to nicotine in a rat model of novelty-seeking behavior: correlation with hippocampal 5HT. Psychopharmacology (Berl.) 2009, 203:23-32.
3. Bjijou Y., De Deurwaerdere P., Spampinato U., Stinus L., Cador M. d-amphetamine-induced behavioral sensitization: effects of lesioning dopaminergic terminals in the medial prefrontal cortex, amygdala and the entorhinal cortex. Neuroscience 2002, 109:499-516.
4. Bura S.A., Burokas A., Martín-García E., Maldonado R. Effects of chronic nicotine on food intake and anxiety-like behaviour in CB(1) knockout mice. Eur. Neuropsychopharmacol. 2010, 6:369-378.
5. Barsy B., Leveleki C., Zelena D., Haller J. The context specificity of anxiety responses induced by chronic psychosocial stress in rats: a shift from anxiety to social phobia?. Stress 2010, 13:230-237.
6. George O., Ghozland S., Azar M.R., Cottone P., Zorrilla E.P., Parsons L.H., O'Dell L.E., Richardson H.N., Koob G.F. CRF-CRF1 system activation mediates withdrawal induced increases in nicotine self-administration in nicotine-dependent rats. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:17198-17203.
7. Heilig M., Koob G.F., Ekman R., Britton K.T. Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. Trends Neurosci. 1994, 17:80-85.
8. Heilig M. The NPY system in stress, anxiety and depression. Neuropeptides 2004, 38:213-224.
9. Isgor C., Huang G.C., Akil H., Watson S.J. Correlation of estrogen β-receptor messenger RNA with endogenous levels of plasma estradiol and progesterone in the female rat hypothalamus, bed nucleus of stria terminalis and the medial amygdala. Brain Res. Mol. Brain Res. 2002, 106:30-41.
10. King P.J., Williams G., Doods H., Widdowson P.S. Effect of a selective neuropeptide Y Y(2) receptor antagonist, BIIE0246 on neuropeptide Y release. Eur. J. Pharmacol. 2000, 396:R1-R3.
11. Koob G.F., Markou A., Weiss F., Schulteis G. Opponent process and drug dependence: neurobiological mechanisms. Semin. Neurosci. 1993, 5:351-358.
12. Koob G.F. Stress, corticotropin-releasing factor, and drug addiction. Ann. NY Acad. Sci. 1999, 897:27-45.
13. Koob G.F. A role for brain stress systems in addiction. Neuron 2008, 59:11-34.
14. Koob G.F., Le Moal M. Review. Neurobiological mechanisms for opponent motivational processes in addiction. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2008, 363:3113-3123.
15. Manhães A.C., Guthierrez M.C., Filgueiras C.C., Abreu-Villaça Y. Anxiety-like behavior during nicotine withdrawal predict subsequent nicotine consumption in adolescent C57BL/6 mice. Behav. Brain Res. 2008, 193:216-224.
16. McQuiston A.R., Colmers W.F. Neuropeptide Y2 receptors inhibit the frequency of spontaneous but not miniature EPSCs in CA3 pyramidal cells of rat hippocampus. J. Neurophysiol. 1996, 76:3159-3168.
17. Pandey S.C. Anxiety and alcohol abuse disorders: a common role for CREB and its target, the neuropeptide Y gene. Trends Pharmacol. Sci. 2003, 24:456-460.
18. Rylkova D., Boissoneault J., Isaac S., Prado M., Shah H.P., Bruijnzeel A.W. Effects of NPY and the specific Y1 receptor agonist [d-His(26)]-NPY on the deficit in brain reward function and somatic signs associated with nicotine withdrawal in rats. Neuropeptides 2008, 42:215-227.
19. Sajdyk T.J., Schober D.A., Gehlert D.R. Neuropeptide Y receptor subtypes in the basolateral nucleus of the amygdala modulate anxiogenic responses in rats. Neuropharmacology 2002, 43:1165-1172.
20. Schmajuk NA, Tyberg M The hippocampal lesion model of schizophrenia, Neuromethods. Animal Models in Psychiatry I 1991, vol 18. Humana Press, Clifton, NJ.
21. Slawecki C.J., Thorsell A.K., El Khoury A., Mathe A.A., Ehlers C.L. Increased CRF-like and NPY-like immunoreactivity in adult rats exposed to nicotine during adolescence: relation to anxiety-like and depressive-like behavior. Neuropeptides 2005, 39:369-377.
22. Sorensen G., Lindberg C., Wortwein G., Bolwig T.G., Woldbye D.P.D. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation. J. Neurosci. 2004, 77:723-729.
23. Suto N., Austin J.D., Vezina P. Locomotor response to novelty predicts a rat's propensity to self-administer nicotine. Psychopharmacology (Berl.) 2001, 158:175-180.
24. Thorsell A., Rimondini R., Heilig M. Blockade of central neuropeptide Y (NPY) Y2 receptors reduces ethanol self-administration. Neurosci. Lett. 2002, 332:1-4.